Tamoxifen: Dr. Jekyll and Mr. Hyde?

Hayes DF. Tamoxifen: Dr. Jekyll and Mr. Hyde? J Natl Cancer Inst. 2004 Jun 16; 96(12):895-7.

View in: PubMed

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Breast Neoplasms
Carcinoma, Ductal, Breast
Chemotherapy, Adjuvant
Clinical Trials as Topic
Drug Resistance, Neoplasm
Enzyme Inhibitors
Epidermal Growth Factor
Female
Humans
Neoplasms, Hormone-Dependent
Phosphorylation
Quinazolines
Receptor Cross-Talk
Receptor, ErbB-2
Receptors, Estrogen
Retrospective Studies
Selective Estrogen Receptor Modulators
Tamoxifen
Trastuzumab

Daniel Hayes

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement